Dario Ballinari

发表

The TPM3‐NTRK1 rearrangement is a recurring event in colorectal carcinoma and is associated with tumor sensitivity to TRKA kinase inhibition

Andrea Lombardi Borgia, Antonella Isacchi, Roberta Bosotti, 2014, Molecular oncology.

In vitro cell growth pharmacodynamic studies: a new nonparametric approach to determining the relative importance of drug concentration and treatment time

Giuseppe De Nicolao, Paolo Magni, Italo Poggesi, 2003, Cancer Chemotherapy and Pharmacology.

PHA-739358, a potent inhibitor of Aurora kinases with a selective target inhibition profile relevant to cancer

Paola Storici, Cristina Alli, Maurizio Rocchetti, 2007, Molecular Cancer Therapeutics.

Cell line identity finding by fingerprinting, an optimized resource for short tandem repeat profile authentication.

Angelo Nuzzo, Antonella Isacchi, Roberta Bosotti, 2013, Genetic testing and molecular biomarkers.